MICHAEL C MACDONALD Insider Trading
Get free email notifications about insider trading for MICHAEL C MACDONALD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Get the latest insider transactions of MICHAEL C MACDONALD. MICHAEL C MACDONALD is a Senior Vice President in XEROX CORP ($XRX) and an Chief Executive Officer in MEDIFAST INC ($MED) and a Director in MEDIFAST INC ($MED) and a Exec Chairman of the Board in MEDIFAST INC ($MED).
Over the past year MICHAEL C MACDONALD has been an insider in 1 company. The total value of shares held by MICHAEL C MACDONALD in this company amounts to $14,129,469.
MICHAEL C MACDONALD ranks 2,731 out of 350,000 insiders. Go to Insider Ranking to see more.
Address: 800 LONG RIDGE ROAD P. O. BOX 1600 STAMFORD 06904 CT
Companies in which MICHAEL C MACDONALD is an InsiderMED
Industry: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS 
Position of MICHAEL C MACDONALD: Director, Exec Chairman of the Board, Chief Executive Officer
Holdings: 334,188 shares
Current Value: $14,129,469
Latest Transaction: Mar 13 2018
$MED Market Capitalization: $504.25M
$MED Previous Close: $42.28
Last 4 weeks trend: SELL
Last 3 months trend: SELL View transactions
Last 3 Months Overview:
Shares Bought: 54,900
Shares Sold: 80,200
Share Difference: -25,300
Value Difference: +$5,597,582XRX
Industry: COMPUTER PERIPHERAL EQUIPMENT, NEC 
Position of MICHAEL C MACDONALD: Senior Vice President
Holdings: 22,307 shares
Current Value: $157,710
Latest Transaction: May 02 2007
$XRX Market Capitalization: $7.47B
$XRX Previous Close: $7.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL C MACDONALD
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Mar 13 2018||MED||MEDIFAST INC||MACDONALD MICHAEL C||Director||Sell||S||88.96||20,000||1,779,200||314,188||334.2 K to 314.2 K (-5.98 %)|
|Mar 13 2018||MED||MEDIFAST INC||MACDONALD MICHAEL C||Director||Sell||S||84.45||20,000||1,689,000||334,188||354.2 K to 334.2 K (-5.65 %)|
|Feb 09 2018||MED||MEDIFAST INC||MACDONALD MICHAEL C||Director||Grant||A||0.00||1,280||0||354,188||352.9 K to 354.2 K (+0.36 %)|
|Feb 09 2018||MED||MEDIFAST INC||MACDONALD MICHAEL C||Director||Payment of Exercise||F||69.81||15,200||1,061,112||352,908||368.1 K to 352.9 K (-4.13 %)|
|Feb 21 2017||MED||MEDIFAST INC||MACDONALD MICHAEL C||Exec Chairman of th ...||Payment of Exercise||F||45.07||8,000||360,560||368,108||376.1 K to 368.1 K (-2.13 %)|
|Feb 21 2017||MED||MEDIFAST INC||MACDONALD MICHAEL C||Exec Chairman of th ...||Grant||A||0.00||15,620||0||376,108||360.5 K to 376.1 K (+4.33 %)|
|Feb 21 2017||MED||MEDIFAST INC||MACDONALD MICHAEL C||Exec Chairman of th ...||Grant||A||0.00||38,000||0||360,488||322.5 K to 360.5 K (+11.78 %)|